Michael R. Stratton

ORCID: 0000-0001-6035-153X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • BRCA gene mutations in cancer
  • DNA Repair Mechanisms
  • Genomic variations and chromosomal abnormalities
  • Genomics and Rare Diseases
  • Epigenetics and DNA Methylation
  • Genetics, Bioinformatics, and Biomedical Research
  • Genomics and Phylogenetic Studies
  • Evolution and Genetic Dynamics
  • Genomics and Chromatin Dynamics
  • CRISPR and Genetic Engineering
  • RNA modifications and cancer
  • Renal and related cancers
  • Genetics and Neurodevelopmental Disorders
  • Chromosomal and Genetic Variations
  • Testicular diseases and treatments
  • Lung Cancer Treatments and Mutations
  • Acute Myeloid Leukemia Research
  • Molecular Biology Techniques and Applications
  • Gene expression and cancer classification
  • Bioinformatics and Genomic Networks
  • Cancer-related Molecular Pathways
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Renal cell carcinoma treatment

Wellcome Sanger Institute
2016-2025

Colon and Rectal Surgery Associates
2024

Institute of Cancer Research
2004-2023

Wellcome Trust
2002-2023

Boston Medical Center
2018

Maria Fertility Hospital
2017

Radboud University Nijmegen
2016

Dana-Farber Cancer Institute
2016

European Bioinformatics Institute
2005-2016

University of Oslo
2016

Alterations in cancer genomes strongly influence clinical responses to treatment and many instances are potent biomarkers for response drugs. The Genomics of Drug Sensitivity Cancer (GDSC) database (www.cancerRxgene.org) is the largest public resource information on drug sensitivity cells molecular markers response. Data freely available without restriction. GDSC currently contains data almost 75 000 experiments, describing 138 anticancer drugs across 700 cell lines. To identify response,...

10.1093/nar/gks1111 article EN cc-by-nc Nucleic Acids Research 2012-11-22

SummaryThe contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage mutation analysis in 237 families, each with at least four cases cancer, collected the Breast Cancer Linkage Consortium. Families were included without regard occurrence ovarian or other cancers. Overall, disease linked an estimated 52% 32% neither gene 16% (95% confidence interval [CI] 6%–28%), suggesting predisposition genes. The majority (81%) breast-ovarian families due BRCA1, most others (14%)...

10.1086/301749 article EN cc-by-nc-nd The American Journal of Human Genetics 1998-03-01
Ludmil B. Alexandrov Jaegil Kim Nicholas J. Haradhvala Mi Ni Huang Alvin Wei Tian Ng and 95 more Yang Wu Arnoud Boot Kyle Covington Dmitry A. Gordenin Erik N. Bergstrom S. M. Ashiqul Islam Núria López-Bigas Leszek J. Klimczak John R. McPherson Sandro Morganella Radhakrishnan Sabarinathan David A. Wheeler Ville Mustonen Ludmil B. Alexandrov Erik N. Bergstrom Arnoud Boot Paul C. Boutros Kin Chan Kyle Covington Akihiro Fujimoto Gad Getz Dmitry A. Gordenin Nicholas J. Haradhvala Mi Ni Huang S. M. Ashiqul Islam Marat D. Kazanov Jaegil Kim Leszek J. Klimczak Núria López-Bigas Michael S. Lawrence Iñigo Martincorena John R. McPherson Sandro Morganella Ville Mustonen Hidewaki Nakagawa Alvin Wei Tian Ng Paz Polak Stephenie D. Prokopec Steven A. Roberts Steve Rozen Radhakrishnan Sabarinathan Natalie Saini Tatsuhiro Shibata Yuichi Shiraishi Michael R. Stratton Bin Tean Teh Ignacio Vázquez-Garćıa David A. Wheeler Yang Wu Fouad Yousif Willie Yu Gad Getz Steve Rozen Michael R. Stratton Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov Adrian Ally Kathryn Alsop Eva G. Álvarez Fernanda Amary Samirkumar B. Amin Brice Aminou Ole Ammerpohl Matthew J. Anderson Yeng Ang Davide Antonello Pavana Anur Samuel Aparício Elizabeth L. Appelbaum Yasuhito Arai Axel Aretz Koji Arihiro Shun‐ichi Ariizumi Joshua Armenia Laurent Arnould L. Sylvia Yassen Assenov Gurnit Atwal Sietse Aukema

Abstract Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic signature 1 . Here, as part the Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium 2 International Cancer Genome (ICGC) and The Atlas (TCGA), we characterized signatures using 84,729,690 somatic from 4,645 whole-genome 19,184 exome sequences that encompass most types cancer. We identified 49 single-base-substitution, 11 doublet-base-substitution, 4...

10.1038/s41586-020-1943-3 article EN cc-by Nature 2020-02-05
Douglas F. Easton Karen A. Pooley Alison M. Dunning Paul D.P. Pharoah Deborah J. Thompson and 95 more Dennis G. Ballinger Jeffery P. Struewing Jonathan J. Morrison Helen I. Field Robert Luben Nicholas J. Wareham Shahana Ahmed Catherine S. Healey Richard Bowman Craig Luccarini Don Conroy Mitul Shah Hannah Munday Clare Jordan Barbara Perkins Judy West Karen Redman Kristy Driver Kerstin B. Meyer Christopher A. Haiman Laurence Kolonel Brian E. Henderson Loı̈c Le Marchand Paul Brennan Suleeporn Sangrajrang Valérie Gaborieau Fabrice Odefrey Chen‐Yang Shen Pei‐Ei Wu Hui‐Chun Wang Diana Eccles D. Gareth Evans Julian Peto Olivia Fletcher Nichola Johnson Sheila Seal Michael R. Stratton Nazneen Rahman Georgia Chenevix‐Trench Stig E. Bojesen Børge G. Nordestgaard C. K. Axelsson Montserrat García‐Closas Louise A. Brinton Stephen J. Chanock Jolanta Lissowska Beata Pepłońska Heli Nevanlinna Rainer Fagerholm Hannaleena Eerola Daehee Kang Keun-Young Yoo Dong‐Young Noh Sei Hyun Ahn David J. Hunter Susan E. Hankinson David G. Cox Per Hall Sara Wedrén Jianjun Liu Yen-Ling Low Natalia Bogdanova Peter Schürmann Thilo Dörk Rob A.�E.�M. Tollenaar Catharina E. Jacobi Peter Devilee Jan G.M. Klijn Alice J. Sigurdson Michele M. Doody Bruce H. Alexander Jinghui Zhang Angela Cox Ian W. Brock Gordon R. Macpherson Malcolm Reed Fergus J. Couch Ellen L. Goode Janet E. Olson Hanne Meijers‐Heijboer Ans van den Ouweland André G. Uitterlinden Fernando Rivadeneira Roger L. Milne Glòria Ribas Anna González‐Neira Javier Benı́tez John L. Hopper Margaret McCredie Melissa C. Southey Graham G. Giles Chris Schroen Christina Justenhoven Hiltrud Brauch Ute Hamann

10.1038/nature05887 article EN Nature 2007-05-27

Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which term chromothripsis, whereby tens hundreds of genomic rearrangements occur in one-off cellular crisis. Rearrangements involving one or few chromosomes crisscross back forth across involved regions, generating frequent oscillations between two copy number states. These hallmarks...

10.1016/j.cell.2010.11.055 article EN cc-by Cell 2011-01-01

COSMIC, the Catalogue Of Somatic Mutations In Cancer (http://cancer.sanger.ac.uk) is world's largest and most comprehensive resource for exploring impact of somatic mutations in human cancer. Our latest release (v70; Aug 2014) describes 2 002 811 coding point over one million tumor samples across genes. To emphasize depth knowledge on known cancer genes, mutation information curated manually from scientific literature, allowing very precise definitions disease types patient details....

10.1093/nar/gku1075 article EN cc-by Nucleic Acids Research 2014-10-29
Thomas J. Hudson Warwick P. Anderson Axel Aretz Anna D. Barker Cindy Bell and 95 more Rosa R. Bernabé M. K. Bhan Fabien Calvo Iiro Eerola Daniela S. Gerhard Alan F. Guttmacher Mark S. Guyer Fiona M. Hemsley Jennifer L. Jennings David Kerr Peter Klatt Patrik Kolar Jun Kusuda David P. Lane Frank Laplace Youyong Lu Gerd Nettekoven Brad Ozenberger Jane L. Peterson T. S. Rao Jacques Remacle Alan J. Schafer Tatsuhiro Shibata Michael R. Stratton Joseph G. Vockley Koichi Watanabe Huanming Yang M.M.F. Yuen Bartha Maria Knoppers Martin Bobrow Anne Cambon‐Thomsen Lynn G. Dressler Stephanie O. M. Dyke Yann Joly Yoshihiro Kato Karen L. Kennedy Pilar Nicolás Michael Parker Emmanuelle Rial‐Sebbag Carlos M. Romeo-Casabona Kenna M. Shaw Susan Wallace Georgia L. Wiesner Nikolajs Zeps Peter Lichter Andrew V. Biankin Christian Chabannon Lynda Chin Bruno Clément Enrique de Álava Françoise Degos Martin L. Ferguson Peter Geary D. Neil Hayes Amber L. Johns Arek Kasprzyk Hidewaki Nakagawa Robert Penny Miguel Á. Piris Rajiv Sarin Aldo Scarpa Marc J. van de Vijver P. Andrew Futreal Hiroyuki Aburatani Mónica Bayés David D.L. Bowtell Peter J. Campbel Xavier Estivill Sean M. Grimmond Ivo Gut Martin Hirst Carlos López‐Otín Partha Majumder Marco A. Marra John D. McPherson Zemin Ning Xosé S. Puente Yijun Ruan H.G. Stunnenberg Harold Swerdlow Victor E. Velculescu Richard K. Wilson Hong Xue Liu Yang Paul T. Spellman Gary D. Bader Paul C. Boutros Paul Flicek Gad Getz Roderic Guigó Guangwu Guo David Haussler Simon Heath Tim Hubbard Tao Jiang

10.1038/nature08987 article EN Nature 2010-04-13

COSMIC ( http://www.sanger.ac.uk/cosmic ) curates comprehensive information on somatic mutations in human cancer. Release v48 (July 2010) describes over 136 000 coding almost 542 tumour samples; of the 18 490 genes documented, 4803 (26%) have one or more mutations. Full scientific literature curations are available 83 major cancer and 49 fusion gene pairs (19 new 30 this year) number is continually increasing. Key amongst these TP53, now through a collaboration with IARC p53 database. In...

10.1093/nar/gkq929 article EN cc-by-nc Nucleic Acids Research 2010-10-15

10.1038/nature17676 article EN Nature 2016-04-29

A small proportion of breast cancer, in particular those cases arising at a young age, is due to the inheritance dominant susceptibility genes conferring high risk disease. genomic linkage search was performed with 15 high-risk cancer families that were unlinked BRCA1 locus on chromosome 17q21. This analysis localized second locus, BRCA2 , 6-centimorgan interval 13q12-13. Preliminary evidence suggests confers but, unlike does not confer substantially elevated ovarian cancer.

10.1126/science.8091231 article EN Science 1994-09-30

Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature cancer. Using this information to guide development and application therapies in clinic is challenging. Here, we report how cancer-driven alterations identified 11,289 tumors from 29 tissues (integrating somatic mutations, copy number alterations, DNA methylation, gene expression) can be mapped onto 1,001 molecularly annotated human cell lines correlated with sensitivity 265 drugs. We find...

10.1016/j.cell.2016.06.017 article EN cc-by Cell 2016-07-01

All cancers carry somatic mutations. A subset of these alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder passengers. Here we have sequenced genomes a malignant melanoma lymphoblastoid cell line from same person, providing first comprehensive catalogue mutations an individual cancer. The provides remarkable insights into forces that shaped this genome. dominant mutational signature reflects DNA damage due to...

10.1038/nature08658 article EN cc-by-nc-sa Nature 2009-12-16

How somatic mutations accumulate in normal cells is central to understanding cancer development but poorly understood. We performed ultradeep sequencing of 74 genes small (0.8 4.7 square millimeters) biopsies skin. Across 234 sun-exposed eyelid epidermis from four individuals, the burden averaged two six per megabase cell, similar that seen many cancers, and exhibited characteristic signatures exposure ultraviolet light. Remarkably, multiple are under strong positive selection even...

10.1126/science.aaa6806 article EN Science 2015-05-22
Coming Soon ...